PANOPTES PHARMA GES M B H has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in Australia, Republic of Korea and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SYMBIOMIX THERAPEUTICS LLC, SOFTKEMO PHARMA CORP and Shionogi Inc.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Republic of Korea | 3 | |
#3 | Canada | 2 | |
#4 | Chile | 2 | |
#5 | Israel | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | Hong Kong | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 | |
#13 | Taiwan | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Obermayr Franz | 14 |
#2 | Sperl Stefan | 14 |
#3 | Franz Obermayr | 4 |
#4 | Stefan Sperl | 4 |
#5 | Vitt Daniel | 3 |
#6 | Leban Johann | 3 |
#7 | Baumgartner Roland | 2 |
#8 | Groeppel Manfred | 2 |
#9 | Groeppel Manfred Baumgartner Roland Leban Johann | 1 |
#10 | Sperl Stefan S | 1 |
Publication | Filing date | Title |
---|---|---|
AU2019232153A1 | Ophthalmic formulation | |
SG11201608835VA | Compounds for treating ophthalmic diseases and disorders | |
KR20160136453A | Anti-inflammatory agents as virostatic compounds | |
TW201043228A | Anti-inflammatory agents as virostatic compounds |